Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine in the treatment of autism
IRCT201106101556N25Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of amantadine in Autism Spectrum Disorder (ASD), sponsored by Tehran University of Medical Sciences. Started Jul 2011; status: completed.
02
Drugs
amantadine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on IRCT201106101556N25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201106101556N25.